chartexchange

VIR
Vir Biotechnology, Inc. Common Stock
stockNASDAQ

At CloseOct 2, 2026 3:59:59 PM EDT
11.17USD-1.063%(-0.12)2,180,670
Pre-marketOct 2, 2026 9:28:30 AM EDT
11.63USD+2.967%(+0.33)
After-hoursOct 2, 2026 4:39:30 PM EDT
11.17USD0.000%(-0.00)
Loading…
Loading…
Healthcare
Biotechnology
HQ
San Francisco, CA, USA
Previous Close
$11.29
Beta
1.71
52-Week High
$11.94 2026-09-02
52-Week Low
$4.82 2025-11-07
SMA 50
$10.14
SMA 200
$9.02
Avg. Vol 10D
1.76M
Avg. Vol 30D
2.17M
Avg. Vol 90D
1.96M
Relative Vol
1.01
169.22M
128.76M
19,660,671
0.4100%
2,300,000
Nov 4, 2026 (30d)
Oct 1, 2026
Vir Biotechnology names Aziz Sawaf as CFO · Seeking Alpha
Sep 28, 2026
VIR Profile

vir brings together cutting-edge innovations with leading scientific expertise and management to take on some of the world's most challenging infectious diseases for which solutions are non-existent or inadequate. vir seeks to take a new approach, using breakthroughs in immune programming to manipulate pathogen-host interactions. the company will take a multi-program, multi-platform approach to applying these breakthroughs, guided by rigorous science and driven by medical need.

VIR Performance
PeriodPriceDateChangeBeta
1W10.512026-09-28+6.34%-4.616
1M11.392026-09-04-1.84%1.881
3M10.022026-07-06+11.54%1.245
6M9.062026-04-06+23.36%1.134
1Y5.732025-10-03+95.04%1.713
2Y7.742024-10-04+44.39%—
5Y34.042021-10-04-67.17%1.354
VIR Stock Summary

Vir Biotechnology, Inc. Common Stock (NASDAQ:VIR) stock price today is $11.18, and today's volume is 2,180,670. VIR is down 1.010% today. The 30 day average volume is 2.17M. VIR market cap is $1.89B with 169.22M shares outstanding.